Twist Bioscience Corporation TWST
Price alert —
Sign in to get a one-time email the moment TWST crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · TWST
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -39.8% | -34.9% |
| 2025-12-31 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -29.4% | -31.9% |
| 2025-09-30 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -27.4% | -30.2% |
| 2025-06-30 | $0.1B | $0.0B | $-0.0B | $-0.0B | 21.2% | -31.4% |
| 2025-03-31 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -42.4% | -44.8% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare TWST vs peers
Line TWST up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with TWST
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-04 | -0.60 | -0.53 | -12.6% | +0.9% |
| 2026-02-02 | -0.50 | -0.52 | +3.9% | -1.1% |
| 2025-11-14 | -0.45 | -0.50 | +10.0% | -1.5% |
| 2025-08-04 | -0.47 | -0.57 | +18.1% | -8.9% |
| 2025-05-05 | -0.66 | -0.56 | -17.4% | -8.8% |
| 2025-02-03 | -0.53 | -0.63 | +16.5% | -1.4% |
| 2024-11-18 | -0.59 | -0.69 | +14.9% | -0.3% |
| 2024-08-02 | -0.70 | -0.77 | +8.8% | +5.5% |
| 2024-05-02 | -0.79 | -0.81 | +3.1% | +28.7% |
| 2024-02-02 | -0.75 | -0.77 | +2.6% | -0.5% |
| 2023-11-17 | -0.75 | -0.86 | +13.2% | +3.0% |
| 2023-08-04 | -1.02 | -1.06 | +4.6% | +3.4% |
| 2023-05-05 | -1.06 | -1.10 | +3.4% | +4.0% |
| 2023-02-03 | -0.81 | -1.17 | +30.4% | -6.2% |
| 2022-11-18 | -1.01 | -1.13 | +10.9% | +3.2% |
| 2022-08-05 | -1.08 | -1.31 | +17.4% | +7.2% |
| 2022-05-05 | -1.02 | -1.30 | +21.6% | +0.8% |
| 2022-02-04 | -0.96 | -1.06 | +9.5% | +1.4% |
| 2021-11-22 | -0.88 | -0.80 | -9.9% | -1.5% |
| 2021-08-06 | -0.78 | -0.75 | -4.1% | +1.9% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| TWST ★ | $5B | — | -114.6 | 13.3 | -49.0 | 11.9 | 52.1% | 19.3% | — | -1.07% |
| LLY | $1,023B | 41.8 | 25.5 | 14.2 | 29.3 | 32.8 | 82.8% | 55.5% | 169.9% | 0.90% |
| UNH | $383B | 32.1 | 18.8 | 0.9 | 17.5 | 3.9 | 19.5% | 0.4% | 61.5% | 5.95% |
| JNJ | $599B | 29.3 | 19.4 | 6.1 | 18.1 | 7.4 | 68.1% | 6.6% | -1.0% | — |
| MRK | $307B | 36.0 | 12.9 | 4.7 | 11.9 | 6.7 | 76.7% | 4.9% | — | 4.57% |
| ABBV | $448B | 124.8 | 15.6 | 7.1 | 17.1 | -67.3 | 72.0% | 12.4% | -46.2% | 4.65% |
| PFE | $141B | 19.2 | 8.7 | 2.2 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.77% |
| TMO | $196B | 29.2 | 19.3 | 4.3 | 20.9 | 3.8 | 40.9% | 6.2% | 11.3% | 2.82% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 67.35%
| Holder | Shares | % out |
|---|---|---|
| Artisan Partners Limited Partnership | 6,367,777 | 10.23% |
| ARK Investment Management, LLC | 6,342,733 | 10.19% |
| Blackrock Inc. | 5,554,362 | 8.92% |
| Edgepoint Investment Group Inc. | 5,382,521 | 8.64% |
| William Blair Investment Management, | 5,269,718 | 8.46% |
| State Street Corporation | 3,670,682 | 5.89% |
| Vanguard Portfolio Management LLC | 2,649,101 | 4.25% |
| Vanguard Capital Management LLC | 2,639,044 | 4.24% |
| Invesco Ltd. | 2,171,898 | 3.49% |
| FMR, LLC | 1,889,945 | 3.04% |
Insider activity · 90d
0 buys / 12 sells · ratio 0.0 · Finnhub
- Laponis Adam SELL 110,276 @ $94.33
- Leproust Emily M. SELL 824,039 @ $95.00
- Cho Dennis SELL 105,141 @ $89.75
- Green Paula SELL 120,414 @ $87.32
- Cho Dennis SELL 119,346 @ $87.32
- Leproust Emily M. SELL 842,919 @ $87.32
- Green Paula M 0
- Green Paula SELL 120,705 @ $82.17
- Green Paula SELL 122,733 @ $81.62
- Green Paula M 146,842 @ $23.33
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-13 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-24 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-24 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-24 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-17 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-01 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-01 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-28 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-28 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-28 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-14 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-12 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-06 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-06 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-06 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-06 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-06 | PRIMARY DOCUMENT | view · |
| 10-Q | 2026-05-04 | 10-Q | view · |
| 8-K | 2026-05-04 | 8-K | view · |
| 4 | 2026-04-29 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-16 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-13 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-24 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-24 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-24 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-19 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-25 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-25 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-25 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-25 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-25 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-25 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-19 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-19 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-18 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-17 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-02-17 | FORM 8-K | view · |
| 4 | 2026-02-13 | PRIMARY DOCUMENT | view · |
About TWST
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive cont…
Options picks · TWST
ITM + OTM ideas from the latest scanLoading…
Congress trades · TWST
STOCK Act disclosuresLoading…
SEC filings & insiders · TWST
EDGAR · liveLoading…
Holders · TWST
Institutions & insider activityLoading…